Quantcast

Daily Archives: January 22, 2007

GE Capital: Rewriting Derivatives Accounting

Posted: January 22, 2007 at 4:50 am

From AAO WeblogIt’s been a while since one of these showed up: a derivatives accounting restatement. This morning, General Electric Capital filed a non-reliance 8-K on in its 10-Ks and ...
Read Full Story »

Friday’s Top Biotech and Medical Stocks

Posted: January 22, 2007 at 4:49 am

From BioHealth InvestorBiotechnologyVANDA PHARMACEUTICAL [VNDA] +10.30% EMERGENT BIOSOLUTION [EBS] +9.20% BOSTON LIFE SCIENCES [BLSI] +8.03% LEV PHARMACEUTICALS [LEVP.OB] +6.96% ALFACELL CORP [ACEL] +6.37% Diagnostic SubstancesRG GLBL LIFESTYLS [RGBL.OB] +25.35% OSTEOLOGIX ...
Read Full Story »

Friday’s Top Biotech and Medical Stocks

Posted: January 22, 2007 at 4:49 am

From BioHealth InvestorBiotechnologyVANDA PHARMACEUTICAL [VNDA] +10.30% EMERGENT BIOSOLUTION [EBS] +9.20% BOSTON LIFE SCIENCES [BLSI] +8.03% LEV PHARMACEUTICALS [LEVP.OB] +6.96% ALFACELL CORP [ACEL] +6.37% Diagnostic SubstancesRG GLBL LIFESTYLS [RGBL.OB] +25.35% OSTEOLOGIX ...
Read Full Story »

IBD Weekly Top Ranked Medical Stocks

Posted: January 22, 2007 at 4:47 am

From BioHealth InvestorThe following list represents the top ten medical stocks ranked according to Earnings Per Share and Relative Strength by Investor's Business Daily (1/20/06)scores out of 100 (last week's ...
Read Full Story »

Biotech & Medical Venture Deals Roundup

Posted: January 22, 2007 at 4:46 am

From BioHealth Investorby Adam RubensteinNovaVision (Boca Raton, FL) a non-invasive device that may restore vision loss in stroke and traumatic brain injury patients has raised $20M in Series C. The ...
Read Full Story »

Tiny Biotech Javelin Pharmaceuticals Looking to Crack Pain Killer Market

Posted: January 22, 2007 at 4:44 am

From BioHealth Investorby Andrew VainoJavelin Pharmaceuticals (JAV) is a tiny biotech focused on drug delivery. Their lead compound is Dyloject, an injectable form of pain-killer diclofenac. One of the problems ...
Read Full Story »

Doctor Claims Americans Paid $150M for Stem Cell Treatment Abroad

Posted: January 22, 2007 at 4:41 am

From BioHealth Investorby H.S. AyoubBioHealth Investor.comThe FDA issued a warning letter to Dr.Alfred T Sapse of Stem Cell Pharma, Inc., a Las Vegas company, alleging that the doctor and the ...
Read Full Story »

Abbott or GE – who is smarter?

Posted: January 22, 2007 at 4:39 am

By Vitaliy Katsenelson, CFAI am not a buyer of Abbott Labs(ABT) at this price, as the margin of safety has been depleted by the latest stock appreciation.  But I like ...
Read Full Story »

Explanation of Enterprise Value

Posted: January 22, 2007 at 4:38 am

Posted by David PolonitzaThe following article provides a detailed definition of enterprise value. To determine the proper value of a company, I try to develop an appropriate intrinsic value for ...
Read Full Story »

Key Issues For This Week (Jan 22 to 26, 2007)

Posted: January 22, 2007 at 4:05 am

These are the biggest issues for the play book this week as far as US investors are concerned.  There are literally a few hundred companies reporting earnings, and this week ...
Read Full Story »

Last Week’s Cramer Recap

Posted: January 22, 2007 at 2:30 am

This is a brief review that willdirect you to Cramer's comments this last week, although this is ashortened list.  This is a re-run of yesterday morning's article incase you missed ...
Read Full Story »